New medications for the treatment of dumping syndrome are actively being developed and evaluated in clinical trials. These investigations focus on novel compounds that act similarly to octreotide but may potentially have fewer side effects. While initial findings appear promising, more comprehensive clinical studies are required to fully confirm their efficacy and safety.